trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Abnormalities, Multiple D000015 13 associated lipids
Adenocarcinoma D000230 166 associated lipids
Adenocarcinoma, Papillary D000231 2 associated lipids
Adrenoleukodystrophy D000326 29 associated lipids
Alzheimer Disease D000544 76 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Asthma D001249 52 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Biliary Tract Neoplasms D001661 7 associated lipids
Body Weight D001835 333 associated lipids
Brain Neoplasms D001932 15 associated lipids
Breast Neoplasms D001943 24 associated lipids
Carcinoma D002277 18 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Carcinoma, Renal Cell D002292 12 associated lipids
Cat Diseases D002371 12 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Cell Transformation, Viral D002472 26 associated lipids
Chondrosarcoma D002813 9 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Bai L and Merchant JL ATM phosphorylates ZBP-89 at Ser202 to potentiate p21waf1 induction by butyrate. 2007 Biochem. Biophys. Res. Commun. pmid:17560543
Rigamonti D et al. Loss of huntingtin function complemented by small molecules acting as repressor element 1/neuron restrictive silencer element silencer modulators. 2007 J. Biol. Chem. pmid:17565993
Huang JC et al. Changes in histone acetylation during postovulatory aging of mouse oocyte. 2007 Biol. Reprod. pmid:17582009
Lee S et al. Design, synthesis, and evaluation of isoindolinone-hydroxamic acid derivatives as histone deacetylase (HDAC) inhibitors. 2007 Bioorg. Med. Chem. Lett. pmid:17588744
Castro-Galache MD et al. Protein kinase C-alpha antagonizes apoptosis induction by histone deacetylase inhibitors in multidrug resistant leukaemia cells. 2007 Int. J. Biochem. Cell Biol. pmid:17588800
Henkens T et al. Trichostatin A, a critical factor in maintaining the functional differentiation of primary cultured rat hepatocytes. 2007 Toxicol. Appl. Pharmacol. pmid:17125810
Nagashima T et al. Histone acetylation and subcellular localization of chromosomal protein BRD4 during mouse oocyte meiosis and mitosis. 2007 Mol. Hum. Reprod. pmid:17267518
Fang S et al. Coordinated recruitment of histone methyltransferase G9a and other chromatin-modifying enzymes in SHP-mediated regulation of hepatic bile acid metabolism. 2007 Mol. Cell. Biol. pmid:17145766
Liu TX et al. Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation. 2007 Nat. Med. pmid:17159988
Liu L and Clipstone NA Prostaglandin F2alpha inhibits adipocyte differentiation via a G alpha q-calcium-calcineurin-dependent signaling pathway. 2007 J. Cell. Biochem. pmid:16888802
Loudni L et al. Design, synthesis and biological evaluation of 1,4-benzodiazepine-2,5-dione-based HDAC inhibitors. 2007 Bioorg. Med. Chem. Lett. pmid:17624773
Kato N et al. Regulation of the expression of MHC class I-related chain A, B (MICA, MICB) via chromatin remodeling and its impact on the susceptibility of leukemic cells to the cytotoxicity of NKG2D-expressing cells. 2007 Leukemia pmid:17625602
Bu Y and Gelman IH v-Src-mediated down-regulation of SSeCKS metastasis suppressor gene promoter by the recruitment of HDAC1 into a USF1-Sp1-Sp3 complex. 2007 J. Biol. Chem. pmid:17626016
Dombrowsky H and Uhlig S Steroids and histone deacetylase in ventilation-induced gene transcription. 2007 Eur. Respir. J. pmid:17626110
Zampetaki A et al. Lacking cytokine production in ES cells and ES-cell-derived vascular cells stimulated by TNF-alpha is rescued by HDAC inhibitor trichostatin A. 2007 Am. J. Physiol., Cell Physiol. pmid:17626239
Strobl JS et al. Scriptaid and suberoylanilide hydroxamic acid are histone deacetylase inhibitors with potent anti-Toxoplasma gondii activity in vitro. 2007 J. Parasitol. pmid:17626366
Ho AK et al. Acetylation of histone H3 and adrenergic-regulated gene transcription in rat pinealocytes. 2007 Endocrinology pmid:17628002
Gahr S et al. The combination of the histone-deacetylase inhibitor trichostatin A and gemcitabine induces inhibition of proliferation and increased apoptosis in pancreatic carcinoma cells. 2007 Int. J. Oncol. pmid:17671683
Tomita A et al. Epigenetic regulation of CD20 protein expression in a novel B-cell lymphoma cell line, RRBL1, established from a patient treated repeatedly with rituximab-containing chemotherapy. 2007 Int. J. Hematol. pmid:17675267
Wang J et al. Histone deacetylase inhibitors suppress TF-kappaB-dependent agonist-driven tissue factor expression in endothelial cells and monocytes. 2007 J. Biol. Chem. pmid:17675290
Di Renzo F et al. Boric acid inhibits embryonic histone deacetylases: a suggested mechanism to explain boric acid-related teratogenicity. 2007 Toxicol. Appl. Pharmacol. pmid:17320131
Xin C et al. FTY720 suppresses interleukin-1beta-induced secretory phospholipase A2 expression in renal mesangial cells by a transcriptional mechanism. 2007 Br. J. Pharmacol. pmid:17325654
Hishiki T et al. BCL3 acts as a negative regulator of transcription from the human T-cell leukemia virus type 1 long terminal repeat through interactions with TORC3. 2007 J. Biol. Chem. pmid:17644518
Huber LC et al. Trichostatin A prevents the accumulation of extracellular matrix in a mouse model of bleomycin-induced skin fibrosis. 2007 Arthritis Rheum. pmid:17665426
Ishihara K et al. Differentiation of eosinophilic leukemia EoL-1 cells into eosinophils induced by histone deacetylase inhibitors. 2007 Life Sci. pmid:17258775
Putignano E et al. Developmental downregulation of histone posttranslational modifications regulates visual cortical plasticity. 2007 Neuron pmid:17329213
Vibhakar R et al. Dickkopf-1 is an epigenetically silenced candidate tumor suppressor gene in medulloblastoma. 2007 Neuro-oncology pmid:17329407
Pan L et al. Histone deacetylase inhibitor trichostatin a potentiates doxorubicin-induced apoptosis by up-regulating PTEN expression. 2007 Cancer pmid:17330857
Robertson DM et al. Insulin-like Growth Factor Binding Protein-3 expression in the human corneal epithelium. 2007 Exp. Eye Res. pmid:17709104
Chen WY et al. Histone deacetylase inhibitors reduce steroidogenesis through SCF-mediated ubiquitination and degradation of steroidogenic factor 1 (NR5A1). 2007 Mol. Cell. Biol. pmid:17709382
D'Alessio AC et al. Acetylation-induced transcription is required for active DNA demethylation in methylation-silenced genes. 2007 Mol. Cell. Biol. pmid:17709385
Tsaprouni LG et al. Suppression of lipopolysaccharide- and tumour necrosis factor-alpha-induced interleukin (IL)-8 expression by glucocorticoids involves changes in IL-8 promoter acetylation. 2007 Clin. Exp. Immunol. pmid:17711487
Markova NG et al. Inhibition of histone deacetylation promotes abnormal epidermal differentiation and specifically suppresses the expression of the late differentiation marker profilaggrin. 2007 J. Invest. Dermatol. pmid:17195011
Yasukawa K et al. Histone deacetylase inhibitors preferentially augment transient transgene expression in human dermal fibroblasts. 2007 Br. J. Dermatol. pmid:17711521
Fujita Y et al. Priming of centromere for CENP-A recruitment by human hMis18alpha, hMis18beta, and M18BP1. 2007 Dev. Cell pmid:17199038
Han S et al. HDAC inhibitors TSA and sodium butyrate enhanced the human IL-5 expression by altering histone acetylation status at its promoter region. 2007 Immunol. Lett. pmid:17270283
Kovács P et al. Effect of histone deacetylase inhibitor trichostatin A (TSA) on the microtubular system of Tetrahymena. 2007 Acta. Biol. Hung. pmid:18277464
Wu P et al. [Role of human telomerase reverse transcriptase in apoptosis of human umbilical vein endothelial cells induced by trichostatin A]. 2007 Zhonghua Zhong Liu Za Zhi pmid:17892126
Akao Y et al. Downregulation of microRNAs-143 and -145 in B-cell malignancies. 2007 Cancer Sci. pmid:17892514
Murga M et al. Global chromatin compaction limits the strength of the DNA damage response. 2007 J. Cell Biol. pmid:17893239
Schnur N et al. The histone deacetylase inhibitor trichostatin A mediates upregulation of 5-lipoxygenase promoter activity by recruitment of Sp1 to distinct GC-boxes. 2007 Biochim. Biophys. Acta pmid:17894944
Oshima M et al. Molecular mechanism of transcriptional repression of AhR repressor involving ANKRA2, HDAC4, and HDAC5. 2007 Biochem. Biophys. Res. Commun. pmid:17949687
Itoh Y et al. Design, synthesis, structure--selectivity relationship, and effect on human cancer cells of a novel series of histone deacetylase 6-selective inhibitors. 2007 J. Med. Chem. pmid:17929798
Ondrousková E et al. A proteomic analysis of protein variations during differentiation of v-myb-transformed monoblasts. 2007 Leuk. Res. pmid:16930693
Scott SA et al. Zebularine inhibits human acute myeloid leukemia cell growth in vitro in association with p15INK4B demethylation and reexpression. 2007 Exp. Hematol. pmid:17258075
Hummel M et al. Transcriptional reactivation of murine cytomegalovirus ie gene expression by 5-aza-2'-deoxycytidine and trichostatin A in latently infected cells despite lack of methylation of the major immediate-early promoter. 2007 J. Gen. Virol. pmid:17374752
Appanah R et al. An unmethylated 3' promoter-proximal region is required for efficient transcription initiation. 2007 PLoS Genet. pmid:17305432
Wee G et al. Epigenetic alteration of the donor cells does not recapitulate the reprogramming of DNA methylation in cloned embryos. 2007 Reproduction pmid:18042635
Bui HT et al. Regulation of chromatin and chromosome morphology by histone H3 modifications in pig oocytes. 2007 Reproduction pmid:17307905
Hattori N et al. Epigenetic regulation of Nanog gene in embryonic stem and trophoblast stem cells. 2007 Genes Cells pmid:17352742
Kwon HS et al. Retinoic acids and trichostatin A (TSA), a histone deacetylase inhibitor, induce human pyruvate dehydrogenase kinase 4 (PDK4) gene expression. 2006 Mar-Apr Biochim. Biophys. Acta pmid:16757381
Mukhopadhyay NK et al. Effectiveness of trichostatin A as a potential candidate for anticancer therapy in non-small-cell lung cancer. 2006 Ann. Thorac. Surg. pmid:16488717
Swanson S Invited commentary. 2006 Ann. Thorac. Surg. pmid:16488718
Song YF et al. High-frequency promoter hypermethylation of the deleted in liver cancer-1 gene in multiple myeloma. 2006 J. Clin. Pathol. pmid:16489177
Rokhlin OW et al. Mechanisms of cell death induced by histone deacetylase inhibitors in androgen receptor-positive prostate cancer cells. 2006 Mol. Cancer Res. pmid:16513842
Endo T et al. Activities of maturation-promoting factor (MPF) and mitogen-activated protein kinase (MAPK) are not required for the global histone deacetylation observed after germinal vesicle breakdown (GVBD) in porcine oocytes. 2006 Reproduction pmid:16514187
Sah NK et al. Effect of downregulation of survivin expression on radiosensitivity of human epidermoid carcinoma cells. 2006 Int. J. Radiat. Oncol. Biol. Phys. pmid:17011457
Kumar KS et al. Histone deacetylase inhibitors induce cell death in supratentorial primitive neuroectodermal tumor cells. 2006 Oncol. Rep. pmid:17016591
Alao JP et al. Role of glycogen synthase kinase 3 beta (GSK3beta) in mediating the cytotoxic effects of the histone deacetylase inhibitor trichostatin A (TSA) in MCF-7 breast cancer cells. 2006 Mol. Cancer pmid:17018141
Kishigami S et al. Epigenetic abnormalities of the mouse paternal zygotic genome associated with microinsemination of round spermatids. 2006 Dev. Biol. pmid:16325170
Mogal A and Abdulkadir SA Effects of Histone Deacetylase Inhibitor (HDACi); Trichostatin-A (TSA) on the expression of housekeeping genes. 2006 Mol. Cell. Probes pmid:16326072
Gan Y et al. Dual effects of histone deacetylase inhibition by trichostatin A on endothelial nitric oxide synthase expression in endothelial cells. 2006 Biochem. Biophys. Res. Commun. pmid:16338217
Nishiyama A et al. Brd4 is required for recovery from antimicrotubule drug-induced mitotic arrest: preservation of acetylated chromatin. 2006 Mol. Biol. Cell pmid:16339075
Trapp J et al. Adenosine mimetics as inhibitors of NAD+-dependent histone deacetylases, from kinase to sirtuin inhibition. 2006 J. Med. Chem. pmid:17149860
Solomon JM et al. Inhibition of SIRT1 catalytic activity increases p53 acetylation but does not alter cell survival following DNA damage. 2006 Mol. Cell. Biol. pmid:16354677
Kishigami S et al. Significant improvement of mouse cloning technique by treatment with trichostatin A after somatic nuclear transfer. 2006 Biochem. Biophys. Res. Commun. pmid:16356478
Baradari V et al. Antiproliferative and proapoptotic effects of histone deacetylase inhibitors on gastrointestinal neuroendocrine tumor cells. 2006 Endocr. Relat. Cancer pmid:17158768
Taghiyev AF et al. TSA-induced cell death in prostate cancer cell lines is caspase-2 dependent and involves the PIDDosome. 2006 Cancer Biol. Ther. pmid:17110788
Hishikawa K and Fujita T [Basic research for renal regeneration]. 2006 Nippon Rinsho pmid:16895225
Meisel A et al. Inhibition of histone deacetylation protects wild-type but not gelsolin-deficient neurons from oxygen/glucose deprivation. 2006 J. Neurochem. pmid:16895577
Krishnan M et al. Effects of epigenetic modulation on reporter gene expression: implications for stem cell imaging. 2006 FASEB J. pmid:16246867
Pampalakis G and Sotiropoulou G Multiple mechanisms underlie the aberrant expression of the human kallikrein 6 gene in breast cancer. 2006 Biol. Chem. pmid:16800739
Wang Y et al. Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts. 2006 Arthritis Rheum. pmid:16802366
Morinobu A et al. Trichostatin A cooperates with Fas-mediated signal to induce apoptosis in rheumatoid arthritis synovial fibroblasts. 2006 J. Rheumatol. pmid:16755652
Son YO et al. Involvement of caspase activation and mitochondrial stress in trichostatin A-induced apoptosis of Burkitt's lymphoma cell line, Akata. 2006 J. Cell. Biochem. pmid:16817225
Lau QC et al. RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer. 2006 Cancer Res. pmid:16818622
Peng C et al. The transcriptional regulation role of BRD7 by binding to acetylated histone through bromodomain. 2006 J. Cell. Biochem. pmid:16265664
Foltz G et al. Genome-wide analysis of epigenetic silencing identifies BEX1 and BEX2 as candidate tumor suppressor genes in malignant glioma. 2006 Cancer Res. pmid:16818640
Mori T et al. Estrogen receptor-alpha methylation predicts melanoma progression. 2006 Cancer Res. pmid:16818643
Sato K et al. Deficient expression of the DPD gene is caused by epigenetic modification in biliary tract cancer cells, and induces high sensitivity to 5-FU treatment. 2006 Int. J. Oncol. pmid:16820886
Qi H and Ratnam M Synergistic induction of folate receptor beta by all-trans retinoic acid and histone deacetylase inhibitors in acute myelogenous leukemia cells: mechanism and utility in enhancing selective growth inhibition by antifolates. 2006 Cancer Res. pmid:16740727
Nusinzon I and Horvath CM Positive and negative regulation of the innate antiviral response and beta interferon gene expression by deacetylation. 2006 Mol. Cell. Biol. pmid:16581785
Ibanez de Caceres I et al. Identification of novel target genes by an epigenetic reactivation screen of renal cancer. 2006 Cancer Res. pmid:16707423
Imre G et al. Histone deacetylase inhibitors suppress the inducibility of nuclear factor-kappaB by tumor necrosis factor-alpha receptor-1 down-regulation. 2006 Cancer Res. pmid:16707469
Jaalouk DE et al. Inhibition of histone deacetylation in 293GPG packaging cell line improves the production of self-inactivating MLV-derived retroviral vectors. 2006 Virol. J. pmid:16603064
Lu Z et al. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer. 2006 Oncogene pmid:16158053
Hwang DY and Ismail-Beigi F Control of Glut1 promoter activity under basal conditions and in response to hyperosmolarity: role of Sp1. 2006 Am. J. Physiol., Cell Physiol. pmid:16162661
Kim MY et al. Acetylation of estrogen receptor alpha by p300 at lysines 266 and 268 enhances the deoxyribonucleic acid binding and transactivation activities of the receptor. 2006 Mol. Endocrinol. pmid:16497729
Leng Y and Chuang DM Endogenous alpha-synuclein is induced by valproic acid through histone deacetylase inhibition and participates in neuroprotection against glutamate-induced excitotoxicity. 2006 J. Neurosci. pmid:16837598
Aung HT et al. LPS regulates proinflammatory gene expression in macrophages by altering histone deacetylase expression. 2006 FASEB J. pmid:16816106
Hong ZY et al. [Mechanism of apoptosis induced by trichostatin A in leukemia Molt-4 cells analyzed by microarray]. 2006 Ai Zheng pmid:16965673
Banwell CM et al. Altered nuclear receptor corepressor expression attenuates vitamin D receptor signaling in breast cancer cells. 2006 Clin. Cancer Res. pmid:16609009
Kim TY et al. Epigenomic profiling reveals novel and frequent targets of aberrant DNA methylation-mediated silencing in malignant glioma. 2006 Cancer Res. pmid:16885346
Kimura N et al. Alteration of developmental program in Paramecium by treatment with trichostatin a: a possible involvement of histone modification. 2006 Protist pmid:16839811
Monte M et al. MAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agents. 2006 Proc. Natl. Acad. Sci. U.S.A. pmid:16847267
Zaveri NT et al. Regulation of the prepronociceptin gene and its effect on neuronal differentiation. 2006 Gene pmid:16935438
Dokras A et al. Epigenetic regulation of maspin expression in the human placenta. 2006 Mol. Hum. Reprod. pmid:16936308
Yamamura K et al. Pleiotropic role of histone deacetylases in the regulation of human adult erythropoiesis. 2006 Br. J. Haematol. pmid:16939493
Das PM et al. Methylation mediated silencing of TMS1/ASC gene in prostate cancer. 2006 Mol. Cancer pmid:16848908
Puppin C et al. HEX expression and localization in normal mammary gland and breast carcinoma. 2006 BMC Cancer pmid:16854221